• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环孢素在人体血液中的分布与浓度

Distribution and concentration of cyclosporin in human blood.

作者信息

Atkinson K, Britton K, Biggs J

出版信息

J Clin Pathol. 1984 Oct;37(10):1167-71. doi: 10.1136/jcp.37.10.1167.

DOI:10.1136/jcp.37.10.1167
PMID:6386891
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC498960/
Abstract

In patients receiving cyclosporin to minimise graft versus host disease after allogeneic bone marrow transplantation, whole blood cyclosporin concentration was roughly twice the serum concentration when blood was separated at 37 degrees C. In turn, blood separation at 37 degrees C resulted in a doubling of serum cyclosporin concentration compared with separation at room temperature. In vitro studies showed that the latter phenomenon was due to a temperature dependent partitioning of cyclosporin between plasma and red cells, such that increased cyclosporin was taken up from the serum into red cells at room temperature. Increasing delay in separation of patient blood (at either temperature) resulted in a gradually increasing cyclosporin serum concentration. Further in vitro studies showed that a distribution equilibrium between blood components was reached within 30 min incubation. Red cell uptake of cyclosporin was saturable at an incubation concentration of greater than 4 microgram/ml, while plasma and mononuclear cells showed a linear uptake to 7 micrograms/ml. The cellular cyclosporin content of a mononuclear cell was roughly 1000 times greater than that of an erythrocyte. For clinical monitoring we recommend the measurement of cyclosporin concentration either in whole blood or in serum separated at 37 degrees C without delay after venepuncture.

摘要

在接受环孢素以尽量减少异基因骨髓移植后移植物抗宿主病的患者中,当血液在37℃下分离时,全血中环孢素浓度约为血清浓度的两倍。反过来,与在室温下分离相比,在37℃下分离血液导致血清环孢素浓度增加一倍。体外研究表明,后一种现象是由于环孢素在血浆和红细胞之间的温度依赖性分配,使得在室温下血清中的环孢素增加被红细胞摄取。患者血液分离延迟增加(在任一温度下)导致环孢素血清浓度逐渐增加。进一步的体外研究表明,在孵育30分钟内血液成分之间达到分布平衡。环孢素在红细胞中的摄取在孵育浓度大于4微克/毫升时达到饱和,而血浆和单核细胞则显示线性摄取至7微克/毫升。单核细胞的细胞内环孢素含量大约比红细胞高1000倍。对于临床监测,我们建议在静脉穿刺后立即测量全血或在37℃下分离的血清中环孢素浓度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a349/498960/74f0d2d29e25/jclinpath00181-0089-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a349/498960/74f0d2d29e25/jclinpath00181-0089-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a349/498960/74f0d2d29e25/jclinpath00181-0089-a.jpg

相似文献

1
Distribution and concentration of cyclosporin in human blood.环孢素在人体血液中的分布与浓度
J Clin Pathol. 1984 Oct;37(10):1167-71. doi: 10.1136/jcp.37.10.1167.
2
Cyclosporin-A radioimmunoassay: a modified method for whole blood determination.环孢素A放射免疫测定法:一种用于全血测定的改良方法。
Exp Hematol. 1985 Oct;13(9):874-8.
3
Stability of cyclosporin A in human serum.环孢素A在人血清中的稳定性。
J Clin Pathol. 1983 Jan;36(1):41-3. doi: 10.1136/jcp.36.1.41.
4
Distribution of cyclosporin G (NVa2 cyclosporin) in blood and plasma.环孢菌素G(NVa2环孢菌素)在血液和血浆中的分布。
Clin Chem. 1993 Feb;39(2):213-7.
5
Effects of temperature and endogenous factors in blood on concentrations of cyclosporin in plasma measured by high-performance liquid chromatography.温度及血液中内源性因素对采用高效液相色谱法测定的血浆中环孢素浓度的影响。
Chem Pharm Bull (Tokyo). 1989 Jul;37(7):1877-80. doi: 10.1248/cpb.37.1877.
6
Effects of sample preparation on concentrations of cyclosporin A measured in plasma.样品制备对血浆中所测环孢素A浓度的影响。
Clin Chem. 1984 Nov;30(11):1812-4.
7
Distribution of cyclosporin A metabolites among plasma and cells in whole blood: effect of temperature, hematocrit, and metabolite concentration.环孢素A代谢产物在全血血浆和细胞中的分布:温度、血细胞比容和代谢产物浓度的影响
Clin Chem. 1989 Jan;35(1):56-63.
8
Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the blood.脂蛋白和红细胞在环孢素A于血液中的体外结合及分布中的作用。
J Pharm Pharmacol. 1982 Nov;34(11):715-8. doi: 10.1111/j.2042-7158.1982.tb06206.x.
9
Cyclosporin: pharmacokinetics and detailed studies of plasma and erythrocyte binding during intravenous and oral administration.
Eur J Clin Pharmacol. 1988;34(5):451-60. doi: 10.1007/BF01046701.
10
Cyclosporin: erythrocyte binding and an examination of its use to estimate unbound concentration.环孢素:红细胞结合及其用于估计游离浓度的研究。
Ther Drug Monit. 1988;10(1):16-9.

引用本文的文献

1
Validation of an automated sample preparation module directly connected to LC-MS/MS (CLAM-LC-MS/MS system) and comparison with conventional immunoassays for quantitation of tacrolimus and cyclosporin A in a clinical setting.直接连接到液相色谱-串联质谱仪的自动化样品制备模块(CLAM-LC-MS/MS系统)的验证以及在临床环境中与传统免疫测定法对他克莫司和环孢素A定量的比较。
J Pharm Health Care Sci. 2024 Jan 8;10(1):5. doi: 10.1186/s40780-023-00318-6.
2
A human proximal tubule-on-a-chip to study renal disease and toxicity.一种用于研究肾脏疾病和毒性的人体近端小管芯片。
Biomicrofluidics. 2019 Feb 1;13(1):014107. doi: 10.1063/1.5083138. eCollection 2019 Jan.
3

本文引用的文献

1
A radioimmunoassay to measure cyclosporin A in plasma and serum samples.一种用于测量血浆和血清样本中环孢素A的放射免疫分析方法。
J Immunoassay. 1981;2(1):19-32. doi: 10.1080/01971528108062989.
2
Use of cyclosporin A in allogeneic bone marrow transplantation for severe aplastic anemia.环孢素A在严重再生障碍性贫血异基因骨髓移植中的应用。
Transplantation. 1982 Apr;33(4):382-6. doi: 10.1097/00007890-198204000-00008.
3
Cyclosporin A hepatotoxicity in 66 renal allograft recipients.66例肾移植受者的环孢素A肝毒性
Mitochondrial permeability transition pore: a potential drug target for neurodegeneration.
线粒体通透性转换孔:神经退行性变的潜在药物靶点。
Drug Discov Today. 2018 Dec;23(12):1983-1989. doi: 10.1016/j.drudis.2018.08.001. Epub 2018 Aug 3.
4
Distribution of cyclosporin in organ transplant recipients.环孢素在器官移植受者体内的分布。
Clin Pharmacokinet. 2002;41(9):615-37. doi: 10.2165/00003088-200241090-00001.
5
Clinically significant drug interactions with cyclosporin. An update.环孢素的具有临床意义的药物相互作用。最新进展。
Clin Pharmacokinet. 1996 Feb;30(2):141-79. doi: 10.2165/00003088-199630020-00004.
6
The use of therapeutic drug monitoring to optimise immunosuppressive therapy.使用治疗药物监测来优化免疫抑制治疗。
Clin Pharmacokinet. 1996 Feb;30(2):107-40. doi: 10.2165/00003088-199630020-00003.
7
Characterization of cyclosporine A uptake in human erythrocytes.
Eur J Clin Pharmacol. 1994;46(5):417-9. doi: 10.1007/BF00191903.
8
Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro.环孢素A在体外可逆转急性淋巴细胞白血病对长春新碱和柔红霉素的耐药性。
J Clin Invest. 1986 Apr;77(4):1405-8. doi: 10.1172/JCI112450.
9
Practical aspects in the use of cyclosporin in paediatric nephrology.环孢素在儿科肾脏病学中应用的实际问题。
Pediatr Nephrol. 1991 Sep;5(5):630-8. doi: 10.1007/BF00856658.
Transplantation. 1981 Dec;32(6):488-9. doi: 10.1097/00007890-198112000-00007.
4
Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury.
N Engl J Med. 1981 Dec 3;305(23):1392-5. doi: 10.1056/NEJM198112033052306.
5
In vitro stability of cyclosporin A.环孢素A的体外稳定性
J Clin Pathol. 1983 Jun;36(6):720-1. doi: 10.1136/jcp.36.6.720.
6
Stability of cyclosporin A in human serum.环孢素A在人血清中的稳定性。
J Clin Pathol. 1983 Jan;36(1):41-3. doi: 10.1136/jcp.36.1.41.
7
Inhibition of T-cell activity by cyclosporin A.环孢菌素A对T细胞活性的抑制作用。
Scand J Immunol. 1981 May;15(5):449-58. doi: 10.1111/j.1365-3083.1982.tb00670.x.
8
Cyclosporin A as prophylaxis against graft-versus-host disease in 36 patients.36例患者应用环孢素A预防移植物抗宿主病
Br Med J (Clin Res Ed). 1982 Jul 17;285(6336):162-6. doi: 10.1136/bmj.285.6336.162.
9
Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease.心肺移植:治疗肺血管疾病患者的成功疗法。
N Engl J Med. 1982 Mar 11;306(10):557-64. doi: 10.1056/NEJM198203113061001.
10
Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2.环孢素A通过损害白细胞介素1和白细胞介素2的释放来介导对原发性细胞毒性T细胞反应的免疫抑制。
Eur J Immunol. 1981 Aug;11(8):657-61. doi: 10.1002/eji.1830110812.